BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10919045)

  • 1. Efficacy of hepatic arterial infusion of prostaglandin E1 in the treatment of postoperative acute liver failure--report of a case.
    Sato T; Asanuma Y; Hashimoto M; Heianna J; Kusano T; Kurokawa T; Yasui O; Koyama K
    Hepatogastroenterology; 2000; 47(33):846-50. PubMed ID: 10919045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of continuous infusion of prostaglandin E1 through the superior mesenteric artery against ischemic liver cell necrosis after hepatic artery occlusion.
    Kato T; Sato T; Kurokawa T; Nanjo H; Asanuma Y; Koyama K
    Transplantation; 2003 Nov; 76(9):1340-5. PubMed ID: 14627913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E(1) continuous hepatic arterial infusion in the treatment of postoperative acute liver failure: basic study on hepatic hemodynamics and clinical application.
    Sato T; Asanuma Y; Kurokawa T; Kato T; Yasui O; Kusano T; Koyama K
    Dig Surg; 2000; 17(3):234-40. PubMed ID: 10867456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of prostaglandin E1 reduces post-operative hepatocellular damage and restores hepatic integrity in patients undergoing hepatectomy.
    Baek Y; Nakano H; Kumada K; Nagasaki H; Kigawa G; Sasaki J; Kaneda M; Hatakeyama T; Kitamura N; Sanada Y; Midorikawa T; Yamaguchi M
    Hepatogastroenterology; 1999; 46(27):1836-41. PubMed ID: 10430356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular carcinoma.
    Hanazaki K; Kajikawa S; Fujimori Y; Nakata S; Shimozawa N; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2000; 47(32):461-4. PubMed ID: 10791213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of prostaglandin E1 on arterial ketone body ratio during and after hepatectomy].
    Nakayama M; Kanaya N; Fujita S; Kawana S; Namiki A
    Masui; 1995 Sep; 44(9):1224-7. PubMed ID: 8523654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intraportal administration of prostaglandin E1 on liver blood flow and liver function.
    Inagaki H; Kurokawa T; Nonami T; Miwa T; Nakao A; Takagi H
    Hepatogastroenterology; 1999; 46(29):2909-13. PubMed ID: 10576371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental study of the effect of intraportal prostaglandin E1 on hepatic blood flow during reperfusion after ischaemia and hepatectomy.
    Hossain MA; Hamamoto I; Wakabayashi H; Goda F; Kobayashi S; Maeba T; Maeta H
    Br J Surg; 1999 Jun; 86(6):776-83. PubMed ID: 10383578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemolipiodolization and prostaglandin E1 administration with use of hepatic arterial infusion port for the treatment of hepatocellular carcinoma and liver cirrhosis.
    Kakizoe S; Kakizoe K; Kakizoe Y; Kakizoe H; Kakizoe T; Kakizoe S
    Hepatogastroenterology; 1996; 43(11):1377-82. PubMed ID: 8908577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraisal of intra-arterial infusion of prostaglandin E1 in patients undergoing major hepatic resection report of four cases.
    Sato T; Yasui O; Kurokawa T; Asanuma Y; Koyama K
    Tohoku J Exp Med; 2001 Oct; 195(2):125-33. PubMed ID: 11846208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous arterial infusion of prostaglandin E(1) via the superior mesenteric artery in the treatment of postoperative liver failure.
    Asanuma Y; Sato T; Kato T; Nanjo H; Kurokawa T; Yasui O; Koyama K
    Ther Apher; 2002 Feb; 6(1):89-92. PubMed ID: 11886583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy].
    Hirashita T; Nakashima K; Sakai M; Sakai I
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1123-6. PubMed ID: 17637554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental study of PGE1 infusion into the liver circulation].
    Ishida T
    Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):898-905. PubMed ID: 3185474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous infusion of prostagrandin E1 during and after gastrectomy on postoperative hepato-renal functions in senile patients].
    Murakawa T; Shimodate Y; Matsuki A; Tanaka T; Takeuchi M; Ino M; Tateoka H; Yokoyama M; Ohishi S
    Masui; 1996 Mar; 45(3):356-61. PubMed ID: 8721140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prostaglandin E1 infused via the superior mesenteric artery on partially resected, dearterialized canine liver.
    Huang HM; Tanaka H; Jin SW; Tanaka S; Yamamoto T; Kubo S; Hirohashi K; Kinoshita H
    Osaka City Med J; 2003 Jun; 49(1):11-9. PubMed ID: 14703095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of low-dose prostaglandin E1 on intra- and post-operative liver function].
    Hayashida M; Hanaoka K; Shimada Y; Namiki A; Amaha K
    Masui; 1997 May; 46(5):618-27. PubMed ID: 9185458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reevaluation of protective effects of alprostadil on hepatic function in patients undergoing hepatectomy].
    Kawano T; Hosokawa N; Maruta T; Maruta N; Takasaki M
    Masui; 2005 Sep; 54(9):982-91. PubMed ID: 16167789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
    Tobari S; Ikeda Y; Takami H
    J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
    Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
    J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of prostaglandin E1 on extravascular lung water in patients with severe heart failure].
    Lenz K; Kranz A; Kramer L; Buder R; Schollmayer E
    Wien Klin Wochenschr; 1996; 108(16):505-9. PubMed ID: 8967094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.